Victrelis

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2011-2014
024620112014

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
The US Food and Drug Administration (FDA) approvals of Gilead’s Sovaldi (sofosbuvir) on December 6 and, to a lesser extent, of… (More)
  • table 1
Is this relevant?
2014
2014
combination regimens for the treatment of chronic HCV infection that include neither interferon nor, in the not-so-distant future… (More)
Is this relevant?
Review
2012
Review
2012
Recent trials evaluated the safety and efficacy of two protease inhibitors, boceprevir (Victrelis) and telaprevir (Incivek… (More)
  • figure 1
Is this relevant?
Review
2012
Review
2012
Recently developed drugs and innovative strategies for the treatment of chronic infection with genotype 1 hepatitis C virus (HCV… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • table 4
Is this relevant?
Review
2012
Review
2012
  • Journal de pharmacie de Belgique
  • 2012
 
Is this relevant?
2012
2012
  • Guy Sabourin
  • Perspective infirmiere : revue officielle de l…
  • 2012
 
Is this relevant?
2011
2011
for people on Victrelis-based triple therapy. But the newly approved drugs also have major shortcomings, adding an extra safety… (More)
  • table 1
Is this relevant?
2011
2011
  • The Medical letter on drugs and therapeutics
  • 2011
 
Is this relevant?
2011
2011
Hepatitis C virus (HCV) remains a major medical problem. Antiviral treatment is only partially effective and a vaccine does not… (More)
  • figure 2
Is this relevant?
2011
2011
963 hit the market, “you’re seeing virtually 100% conversion of patients from the old standard of care to the new,” says Geoffrey… (More)
  • figure 1
  • table 1
Is this relevant?